Details

Autor(en) / Beteiligte

• Tibb, Amit S
• Ennezat, Pierre V
• Chen, Jennifer A
• Haider, Ali
• Gundewar, Susheel
• Cotarlan, Vlad
• Aggarwal, Vimla S
• Talreja, Ashok
• Le Jemtel, Thierry H

Titel

Diabetes lowers aerobic capacity in heart failure

Ist Teil von

• Journal of the American College of Cardiology, 2005-09, Vol.46 (5), p.930-931

Ort / Verlag

United States: Elsevier Limited

Erscheinungsjahr

2005

Link zum Volltext

Quelle

Free E-Journal (出版社公開部分のみ）

Beschreibungen/Notizen

• Multiple linear regression analysis was performed to assess the effect of diabetes on peak Vo2 controlling for hypertension, coronary artery disease (CAD), chronic kidney disease, BNP plasma level, LV ejection fraction, physical activity, and glycosylated hemoglobin. Metoprolol or carvedilol (%) 92.3 86.5 0.20 ACE inhibitor or ARB (%) 92.3 88.1 0.34 Digoxin (%) 52.6 42.8 0.47 Aspirin (%) 71.8 57.1 0.03 Statin (%) 70.9 57.5 0.08 Loop diuretics (%) 85.9 83.3 0.69 Table 1 Characteristics and Medications ACE = angiotensin-converting enzyme; ARB = angiotensin receptor blocker; BMI = body mass index; BNP = B-type natriuretic peptide; CAD = coronary artery disease; CKD = chronic kidney disease; Hgb = hemoglobin; HgbA1c = glycosylated hemoglobin; HTN = hypertension; LVEF = left ventricular ejection fraction.